GSK Investigational Site

Hemer 58675

0 studies enrolling now · 1 studies all time

What they study most

Lung Cancer, Non-Small Cell

Studies at this site

• Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer — Completed